929360071000036103: Medicinal product unit of use reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept\Reference set\Simple type reference set\Medicinal product unit of use reference set

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module

3288211000168116 MPUU (medicinal product unit of use) reference set en Synonym Active Case sensitive Australian Medicines Terminology module

965507151000036113 Medicinal product unit of use reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module

965507161000036111 Medicinal product unit of use reference set en Synonym Active Case sensitive Australian Medicines Terminology module

4351141000168117 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more equivalent Trade Product Units of Use.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Medicinal product unit of use reference set	Developed by	Australian Digital Health Agency	true	Inferred relationship	Some	615170453
Medicinal product unit of use reference set	Has licence	SNOMED CT-AU licence	true	Inferred relationship	Some	1364130978
Medicinal product unit of use reference set	Is a	Simple type reference set	true	Inferred relationship	Some

Members

hepatitis B child vaccine 5 microgram/0.5 mL injection, syringe

hepatitis B child vaccine 5 microgram/0.5 mL injection, vial

hepatitis B virus immunoglobulin 100 units injection, vial

hepatitis B virus immunoglobulin 400 units injection, vial

hexachlorophene 3% lotion

hexaminolevulinate 85 mg injection, vial

hexylresorcinol 2.4 mg lozenge

hexylresorcinol 2.5 mg lozenge

psyllium husk powder 375 mg/g + high amylose maize starch 375 mg/g powder for oral liquid

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (3:1 ratio long chain fat to carbohydrate plus protein) powder for oral liquid

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (3:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 250 mL carton

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio long chain fat to carbohydate plus protein) powder for oral liquid

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio long chain fat to carbohydrate plus protein) oral liquid, 200 mL carton

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio medium chain fat to carbohydrate plus protein) oral liquid, 250 mL carton

high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate oral semi-solid, 100 g tub

high selenium yeast 83.4 mg (selenium 100 microgram) tablet

homatropine hydrobromide 2% eye drops

homosalate 4.5% + menthyl anthranilate 4.8% + octyl methoxycinnamate 7.4% + octyl salicylate 5% + oxybenzone 5.2% stick

honey bee venom 550 microgram injection, vial

human chorionic gonadotrophin 1500 units injection, ampoule

human chorionic gonadotrophin 1500 units injection, vial

human chorionic gonadotrophin 500 units injection, ampoule

human chorionic gonadotrophin 5000 units injection, ampoule

human chorionic gonadotrophin 5000 units injection, vial

human menopausal gonadotrophin 1200 units injection, vial

human menopausal gonadotrophin 600 units injection, vial

human menopausal gonadotrophin 625 units/mL injection, 0.96 mL pen device

human menopausal gonadotrophin 625 units/mL injection, 1.92 mL pen device

human papillomavirus quadrivalent vaccine injection, 0.5 mL syringe

human papillomavirus quadrivalent vaccine injection, 0.5 mL vial

human papillomavirus 9 valent vaccine injection, 0.5 mL syringe

human papillomavirus 9 valent vaccine injection, 0.5 mL vial

human papillomavirus bivalent vaccine injection, 0.5 mL syringe

human papillomavirus bivalent vaccine injection, 0.5 mL vial

human thrombin 1600 units/2 mL solution, vial

human thrombin 4000 units/5 mL solution, vial

human thrombin 800 units/mL solution, vial

hyaluronate sodium 0.1% eye drops

hyaluronate sodium 0.2% eye drops

sodium chondroitin sulfate 40 mg/mL + hyaluronate sodium 30 mg/mL intraocular injection, syringe

hyaluronate sodium 1.6% (800 mg/50 mL) + sodium chondroitin sulfate 2% (1 g/50 mL) injection, syringe

hyaluronic acid 20 mg/mL injection, syringe

hyaluronic acid 20 mg/mL injection, 3 mL syringe

hyaluronidase 1500 units injection, ampoule

hydralazine hydrochloride 20 mg/mL injection, vial

hydralazine hydrochloride 20 mg injection, ampoule

hydralazine hydrochloride 25 mg tablet

hydralazine hydrochloride 50 mg tablet

hydrochloric acid 1 Molar injection, vial

irbesartan 150 mg + hydrochlorothiazide 12.5 mg tablet

irbesartan 300 mg + hydrochlorothiazide 12.5 mg tablet

losartan potassium 50 mg + hydrochlorothiazide 12.5 mg tablet

olmesartan medoxomil 20 mg + hydrochlorothiazide 12.5 mg tablet

hydrochlorothiazide 12.5 mg + olmesartan medoxomil 40 mg tablet (medicinal product unit of use)

quinapril 10 mg + hydrochlorothiazide 12.5 mg tablet

quinapril 20 mg + hydrochlorothiazide 12.5 mg tablet

telmisartan 40 mg + hydrochlorothiazide 12.5 mg tablet

telmisartan 80 mg + hydrochlorothiazide 12.5 mg tablet

valsartan 160 mg + hydrochlorothiazide 12.5 mg tablet

valsartan 320 mg + hydrochlorothiazide 12.5 mg tablet

valsartan 80 mg + hydrochlorothiazide 12.5 mg tablet

irbesartan 300 mg + hydrochlorothiazide 25 mg tablet

losartan potassium 100 mg + hydrochlorothiazide 25 mg tablet

olmesartan medoxomil 20 mg + hydrochlorothiazide 25 mg tablet

olmesartan medoxomil 40 mg + hydrochlorothiazide 25 mg tablet

telmisartan 80 mg + hydrochlorothiazide 25 mg tablet

hydrochlorothiazide 25 mg + triamterene 50 mg tablet

valsartan 160 mg + hydrochlorothiazide 25 mg tablet

valsartan 320 mg + hydrochlorothiazide 25 mg tablet

hydrochlorothiazide 25 mg tablet

hydrocortisone (as sodium succinate) 100 mg injection, chamber

hydrocortisone (as sodium succinate) 100 mg injection, vial

hydrocortisone (as sodium succinate) 250 mg injection, chamber

hydrocortisone (as sodium succinate) 500 mg injection, chamber

hydrocortisone 1 mg granules, capsule

hydrocortisone 1% + miconazole nitrate 2% cream

hydrocortisone 1% cream

hydrocortisone 1% gel

hydrocortisone 1% solution

hydrocortisone 1% spray

hydrocortisone 100 mg injection, vial

hydrocortisone 2 mg granules, capsule

hydrocortisone 20 mg tablet

hydrocortisone 4 mg tablet

lidocaine 5% + hydrocortisone 0.5% ointment

hydrocortisone 0.5% + miconazole nitrate 2% cream

hydrocortisone 0.5% cream

hydrocortisone 5 mg granules, capsule

hydrocortisone 500 microgram granules, capsule

hydrocortisone acetate 1% cream

hydrocortisone acetate 1% eye ointment

hydrocortisone acetate 1% ointment

hydrocortisone acetate 10% enema

lidocaine 5% + hydrocortisone acetate 0.25% ointment

hydrocortisone acetate 0.5% cream

hydrocortisone acetate 0.5% eye ointment

sodium fluoride 2.21% + hydrofluoric acid 0.49% (total fluoride 1.23%) foam

hydrogen peroxide 1% cream

hydrogen peroxide 3% w/w solution

hydrogen peroxide 3% w/v solution

hydrogen peroxide 3% solution, ampoule

Start Previous Page 41 of 75 Next End

Reference Sets

Australian dialect reference set

Reference set descriptor